Is Teladoc Stock a Buy?
Telehealth provider Teladoc Health (NYSE: TDOC) has experienced revolutionary changes to its business due to the COVID-19 pandemic. Before the spread of the virus, only 11% of Americans had sought online care from a physician. In just a matter of months, that metric has shot up to 76% -- and the ease of receiving medical care from the comfort of home is unlikely to be forgotten even when the pandemic ends.
The upsurge in sales isn't the only positive development. Last month, Teladoc completed its multibillion-dollar acquisition of Livongo Health, a premier digital diabetes management company. This serves as a significant catalyst for Teladoc, and one that should propel its stock to new all-time highs. Let's find out why the stock is a solid buy right now.
Image source: Getty Images.
Source Fool.com
